Latest news
Loading news…
Akeila Bio is developing novel small molecule drugs targeting RXR nuclear receptor biology with applications in a variety of disease areas
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Ann Arbor, Michigan, United States
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Akeila Bio
Loading news…
FAQs about Akeila Bio
People who checked this page also checked these
Browse the full Acquirezy directory.